Report cover image

Global Bioconjugation Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Feb 06, 2025
Length 199 Pages
SKU # APRC19976436

Description

Summary

According to APO Research, The global Bioconjugation market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Bioconjugation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Bioconjugation include WuXi Biologics, Thermo Fisher Scientific, Merck, Roche, Lonza, AbbVie, Sartorius, Promega and Piramal Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bioconjugation, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Bioconjugation, also provides the sales of main regions and countries. Of the upcoming market potential for Bioconjugation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bioconjugation sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Bioconjugation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Bioconjugation sales, projected growth trends, production technology, application and end-user industry.

Bioconjugation Segment by Company

WuXi Biologics
Thermo Fisher Scientific
Merck
Roche
Lonza
AbbVie
Sartorius
Promega
Piramal Pharma
Genscript Biotech
Danaher
Charles River Laboratories
Catalent
Bio-Rad Laboratories
BD
Agilent
Bioconjugation Segment by Type

Chemical Conjugation
Click Chemistry
Enzyme-mediated Conjugatio
Others
Bioconjugation Segment by Application

Pharmaceutical
Hosptial
Research Institutes
Others
Bioconjugation Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bioconjugation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioconjugation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bioconjugation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Bioconjugation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Bioconjugation Market Size, 2020 VS 2024 VS 2031
1.3 Global Bioconjugation Market Size Estimates and Forecasts (2020-2031)
1.4 Global Bioconjugation Sales Estimates and Forecasts (2020-2031)
1.5 Global Bioconjugation Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Bioconjugation Market Dynamics
2.1 Bioconjugation Industry Trends
2.2 Bioconjugation Industry Drivers
2.3 Bioconjugation Industry Opportunities and Challenges
2.4 Bioconjugation Industry Restraints
3 Bioconjugation Market by Manufacturers
3.1 Global Bioconjugation Revenue by Manufacturers (2020-2025)
3.2 Global Bioconjugation Sales by Manufacturers (2020-2025)
3.3 Global Bioconjugation Average Sales Price by Manufacturers (2020-2025)
3.4 Global Bioconjugation Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Bioconjugation Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Bioconjugation Manufacturers, Product Type & Application
3.7 Global Bioconjugation Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Bioconjugation Market CR5 and HHI
3.8.2 Global Top 5 and 10 Bioconjugation Players Market Share by Revenue in 2024
3.8.3 2024 Bioconjugation Tier 1, Tier 2, and Tier 3
4 Bioconjugation Market by Type
4.1 Bioconjugation Type Introduction
4.1.1 Chemical Conjugation
4.1.2 Click Chemistry
4.1.3 Enzyme-mediated Conjugatio
4.1.4 Others
4.2 Global Bioconjugation Sales by Type
4.2.1 Global Bioconjugation Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Bioconjugation Sales by Type (2020-2031)
4.2.3 Global Bioconjugation Sales Market Share by Type (2020-2031)
4.3 Global Bioconjugation Revenue by Type
4.3.1 Global Bioconjugation Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Bioconjugation Revenue by Type (2020-2031)
4.3.3 Global Bioconjugation Revenue Market Share by Type (2020-2031)
5 Bioconjugation Market by Application
5.1 Bioconjugation Application Introduction
5.1.1 Pharmaceutical
5.1.2 Hosptial
5.1.3 Research Institutes
5.1.4 Others
5.2 Global Bioconjugation Sales by Application
5.2.1 Global Bioconjugation Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Bioconjugation Sales by Application (2020-2031)
5.2.3 Global Bioconjugation Sales Market Share by Application (2020-2031)
5.3 Global Bioconjugation Revenue by Application
5.3.1 Global Bioconjugation Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Bioconjugation Revenue by Application (2020-2031)
5.3.3 Global Bioconjugation Revenue Market Share by Application (2020-2031)
6 Global Bioconjugation Sales by Region
6.1 Global Bioconjugation Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Bioconjugation Sales by Region (2020-2031)
6.2.1 Global Bioconjugation Sales by Region (2020-2025)
6.2.2 Global Bioconjugation Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Bioconjugation Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Bioconjugation Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Bioconjugation Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Bioconjugation Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Bioconjugation Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Bioconjugation Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Bioconjugation Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Bioconjugation Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Bioconjugation Revenue by Region
7.1 Global Bioconjugation Revenue by Region
7.1.1 Global Bioconjugation Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Bioconjugation Revenue by Region (2020-2025)
7.1.3 Global Bioconjugation Revenue by Region (2026-2031)
7.1.4 Global Bioconjugation Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Bioconjugation Revenue (2020-2031)
7.2.2 North America Bioconjugation Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Bioconjugation Revenue (2020-2031)
7.3.2 Europe Bioconjugation Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Bioconjugation Revenue (2020-2031)
7.4.2 Asia-Pacific Bioconjugation Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Bioconjugation Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Bioconjugation Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 WuXi Biologics
8.1.1 WuXi Biologics Comapny Information
8.1.2 WuXi Biologics Business Overview
8.1.3 WuXi Biologics Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 WuXi Biologics Bioconjugation Product Portfolio
8.1.5 WuXi Biologics Recent Developments
8.2 Thermo Fisher Scientific
8.2.1 Thermo Fisher Scientific Comapny Information
8.2.2 Thermo Fisher Scientific Business Overview
8.2.3 Thermo Fisher Scientific Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Thermo Fisher Scientific Bioconjugation Product Portfolio
8.2.5 Thermo Fisher Scientific Recent Developments
8.3 Merck
8.3.1 Merck Comapny Information
8.3.2 Merck Business Overview
8.3.3 Merck Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Merck Bioconjugation Product Portfolio
8.3.5 Merck Recent Developments
8.4 Roche
8.4.1 Roche Comapny Information
8.4.2 Roche Business Overview
8.4.3 Roche Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Roche Bioconjugation Product Portfolio
8.4.5 Roche Recent Developments
8.5 Lonza
8.5.1 Lonza Comapny Information
8.5.2 Lonza Business Overview
8.5.3 Lonza Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Lonza Bioconjugation Product Portfolio
8.5.5 Lonza Recent Developments
8.6 AbbVie
8.6.1 AbbVie Comapny Information
8.6.2 AbbVie Business Overview
8.6.3 AbbVie Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 AbbVie Bioconjugation Product Portfolio
8.6.5 AbbVie Recent Developments
8.7 Sartorius
8.7.1 Sartorius Comapny Information
8.7.2 Sartorius Business Overview
8.7.3 Sartorius Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Sartorius Bioconjugation Product Portfolio
8.7.5 Sartorius Recent Developments
8.8 Promega
8.8.1 Promega Comapny Information
8.8.2 Promega Business Overview
8.8.3 Promega Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Promega Bioconjugation Product Portfolio
8.8.5 Promega Recent Developments
8.9 Piramal Pharma
8.9.1 Piramal Pharma Comapny Information
8.9.2 Piramal Pharma Business Overview
8.9.3 Piramal Pharma Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Piramal Pharma Bioconjugation Product Portfolio
8.9.5 Piramal Pharma Recent Developments
8.10 Genscript Biotech
8.10.1 Genscript Biotech Comapny Information
8.10.2 Genscript Biotech Business Overview
8.10.3 Genscript Biotech Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Genscript Biotech Bioconjugation Product Portfolio
8.10.5 Genscript Biotech Recent Developments
8.11 Danaher
8.11.1 Danaher Comapny Information
8.11.2 Danaher Business Overview
8.11.3 Danaher Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Danaher Bioconjugation Product Portfolio
8.11.5 Danaher Recent Developments
8.12 Charles River Laboratories
8.12.1 Charles River Laboratories Comapny Information
8.12.2 Charles River Laboratories Business Overview
8.12.3 Charles River Laboratories Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Charles River Laboratories Bioconjugation Product Portfolio
8.12.5 Charles River Laboratories Recent Developments
8.13 Catalent
8.13.1 Catalent Comapny Information
8.13.2 Catalent Business Overview
8.13.3 Catalent Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Catalent Bioconjugation Product Portfolio
8.13.5 Catalent Recent Developments
8.14 Bio-Rad Laboratories
8.14.1 Bio-Rad Laboratories Comapny Information
8.14.2 Bio-Rad Laboratories Business Overview
8.14.3 Bio-Rad Laboratories Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Bio-Rad Laboratories Bioconjugation Product Portfolio
8.14.5 Bio-Rad Laboratories Recent Developments
8.15 BD
8.15.1 BD Comapny Information
8.15.2 BD Business Overview
8.15.3 BD Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 BD Bioconjugation Product Portfolio
8.15.5 BD Recent Developments
8.16 Agilent
8.16.1 Agilent Comapny Information
8.16.2 Agilent Business Overview
8.16.3 Agilent Bioconjugation Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Agilent Bioconjugation Product Portfolio
8.16.5 Agilent Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Bioconjugation Value Chain Analysis
9.1.1 Bioconjugation Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Bioconjugation Production Mode & Process
9.2 Bioconjugation Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Bioconjugation Distributors
9.2.3 Bioconjugation Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.